Clinical Trial Detail

NCT ID NCT02423525
Title Safety Study of Afatinib for Brain Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, San Diego
Indications

malignant leptomeningeal tumor

mixed oligodendroglioma-astrocytoma

astrocytoma

oligodendroglioma

meningioma

malignant glioma

glioblastoma multiforme

Therapies

Afatinib

Age Groups: adult

No variant requirements are available.